Zosano Pharma Corp (ZSAN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre Partager sur 𝕏

Cours de l'action
Code mnémonique : ZSAN Marché : NAS


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette
90 derniers jours
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur totale Détails
2022-06-07 2022-06-06 V Vente

Lo Steven

Chief Executive Officer

Administrateur exécutif
442 -3.2%
0,71
314 USD 		442 -3.2% 0,71 314 USD
2022-06-07 2022-06-06 V Vente

Matthews Christine

Chief Financial Officer

Dirigeant
82 -1.9%
0,71
58 USD 		82 -1.9% 0,71 58 USD
2022-04-01 2022-03-31 V Vente

KELLERMAN DONALD J

VP, Clinical Dev & Med Affairs

Dirigeant
4 006 -6.6%
0,21
842 USD 		4 006 -6.6% 0,21 842 USD
2022-04-01 2022-03-31 V Vente

Matthews Christine

Chief Financial Officer

Dirigeant
8 116 -5.3%
0,21
1 705 USD 		8 116 -5.3% 0,21 1 705 USD
2022-04-01 2022-03-31 V Vente

Lo Steven

Chief Executive Officer

Administrateur exécutif
23 633 -4.9%
0,21
4 965 USD 		23 633 -4.9% 0,21 4 965 USD
2021-11-24 2021-11-23 V Vente

GREATHOUSE KENNETH

Administrateur non-exécutif
10 000 -18.7%
0,60
6 018 USD 		10 000 -18.7% 0,60 6 018 USD
2021-06-07 2021-06-04 V Vente

Lewis Hayley

See Remarks

Dirigeant
1 709 -3.3%
0,81
1 376 USD 		1 709 -3.3% 0,81 1 376 USD
2021-06-07 2021-06-04 V Vente

KELLERMAN DONALD J

VP, Clinical Dev & Med Affairs

Dirigeant
1 709 -3.3%
0,81
1 376 USD 		1 709 -3.3% 0,81 1 376 USD
2021-06-07 2021-06-04 V Vente

Matthews Christine

Chief Financial Officer

Dirigeant
1 709 -1.7%
0,81
1 376 USD 		1 709 -1.7% 0,81 1 376 USD
2019-04-18 2019-04-11 A Achat

WALKER JOHN PETER

President & CEO

Administrateur exécutif
100 000 +55.5%
3,50
350 000 USD 		100 000 +55.5% 3,50 350 000 USD
2018-02-28 2018-02-27 V Vente

Amzak Capital Management, LLC

Large shareholder
5 901 -100.0%
8,26
48 760 USD 		5 901 -100.0% 8,26 48 760 USD
2018-02-28 2018-02-27 V Vente

Amzak Capital Management, LLC

Large shareholder
80 880 -31.6%
8,36
675 914 USD 		80 880 -31.6% 8,36 675 914 USD
2018-02-28 2018-02-26 V Vente

Amzak Capital Management, LLC

Large shareholder
1 500 -0.6%
11,00
16 500 USD 		1 500 -0.6% 11,00 16 500 USD
2017-12-08 2017-12-06 A Achat

GREATHOUSE KENNETH

55 000 +37.9%
0,61
33 407 USD 		55 000 +37.9% 0,61 33 407 USD
2017-12-04 2017-12-01 A Achat

GREATHOUSE KENNETH

50 000 +52.6%
0,62
31 080 USD 		50 000 +52.6% 0,62 31 080 USD
2017-12-04 2017-11-30 A Achat

GREATHOUSE KENNETH

45 000 +90.0%
0,62
27 927 USD 		45 000 +90.0% 0,62 27 927 USD
2017-11-16 2017-11-15 A Achat

GREATHOUSE KENNETH

15 000 +42.9%
0,58
8 675 USD 		15 000 +42.9% 0,58 8 675 USD
2017-11-16 2017-11-14 A Achat

GREATHOUSE KENNETH

35 000 +inf%
0,64
22 484 USD 		35 000 +inf% 0,64 22 484 USD
2017-05-25 2017-05-25 A Achat

Erbez Georgia

CFO and Chief Business Officer

Dirigeant
68 000 +142.4%
1,32
89 760 USD 		68 000 +142.4% 1,32 89 760 USD
2017-05-25 2017-05-25 A Achat

WALKER JOHN PETER

Interim CEO

Administrateur exécutif
37 550 +22.2%
1,37
51 338 USD 		37 550 +22.2% 1,37 51 338 USD
2017-05-25 2017-05-24 A Achat

WALKER JOHN PETER

Interim CEO

Administrateur exécutif
36 166 +27.2%
1,34
48 553 USD 		36 166 +27.2% 1,34 48 553 USD
2017-02-14 2017-02-13 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
1 099 996 -53.6%
2,01
2 211 432 USD 		1 099 996 -53.6% 2,01 2 211 432 USD
2017-02-14 2017-02-13 V Vente

BARRETT M JAMES

Large shareholder
1 099 996 -53.6%
2,01
2 211 432 USD 		1 099 996 -53.6% 2,01 2 211 432 USD
2016-09-20 2016-09-16 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
7 471 -0.4%
0,75
5 603 USD 		7 471 -0.4% 0,75 5 603 USD
2016-09-20 2016-09-16 V Vente

BARRETT M JAMES

Large shareholder
7 471 -0.4%
0,75
5 603 USD 		7 471 -0.4% 0,75 5 603 USD
2016-09-15 2016-09-13 V Vente

BARRETT M JAMES

Large shareholder
10 000 -0.5%
0,74
7 400 USD 		10 000 -0.5% 0,74 7 400 USD
2016-09-15 2016-09-13 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
10 000 -0.5%
0,74
7 400 USD 		10 000 -0.5% 0,74 7 400 USD
2016-08-31 2016-08-29 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
50 000 -2.4%
1,01
50 440 USD 		50 000 -2.4% 1,01 50 440 USD
2016-08-31 2016-08-29 V Vente

BARRETT M JAMES

Large shareholder
50 000 -2.4%
1,01
50 440 USD 		50 000 -2.4% 1,01 50 440 USD
2016-08-26 2016-08-24 V Vente

BARRETT M JAMES

Large shareholder
1 200 -0.1%
1,21
1 452 USD 		1 200 -0.1% 1,21 1 452 USD
2016-08-26 2016-08-24 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
1 200 -0.1%
1,21
1 452 USD 		1 200 -0.1% 1,21 1 452 USD
2016-08-22 2016-08-19 A Achat

Erbez Georgia

Interim CFO

Dirigeant
47 750 +inf%
1,32
63 030 USD 		47 750 +inf% 1,32 63 030 USD
2016-08-22 2016-08-19 A Achat

KELLERMAN DONALD J

VP, Clinical Dev & Med Affairs

Dirigeant
15 920 +inf%
1,32
21 014 USD 		15 920 +inf% 1,32 21 014 USD
2016-08-22 2016-08-19 A Achat

Lewis Hayley

VP, Reg Affairs & Quality

Dirigeant
4 775 +inf%
1,32
6 303 USD 		4 775 +inf% 1,32 6 303 USD
2016-08-22 2016-08-19 A Achat

WALKER JOHN PETER

Administrateur non-exécutif
63 700 +inf%
1,32
84 084 USD 		63 700 +inf% 1,32 84 084 USD
2016-08-22 2016-08-19 A Achat

Alataris Konstantinos

President, CEO

Administrateur exécutif
127 389 +inf%
1,32
168 153 USD 		127 389 +inf% 1,32 168 153 USD
2016-08-22 2016-08-19 A Achat

XANTHOPOULOS KLEANTHIS G

Administrateur non-exécutif
15 920 +265.3%
1,32
21 014 USD 		15 920 +265.3% 1,32 21 014 USD
2016-07-21 2016-07-21 V Vente

BARRETT M JAMES

Large shareholder
8 989 -0.4%
1,33
11 957 USD 		8 989 -0.4% 1,33 11 957 USD
2016-07-21 2016-07-21 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
8 989 -0.4%
1,33
11 957 USD 		8 989 -0.4% 1,33 11 957 USD
2016-07-21 2016-07-20 V Vente

BARRETT M JAMES

Large shareholder
14 158 -0.7%
1,24
17 550 USD 		14 158 -0.7% 1,24 17 550 USD
2016-07-21 2016-07-20 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
14 158 -0.7%
1,24
17 550 USD 		14 158 -0.7% 1,24 17 550 USD
2016-07-21 2016-07-19 V Vente

BARRETT M JAMES

Large shareholder
534 -0.0%
1,17
625 USD 		534 -0.0% 1,17 625 USD
2016-07-21 2016-07-19 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
534 -0.0%
1,17
625 USD 		534 -0.0% 1,17 625 USD
2016-07-15 2016-07-13 V Vente

BARRETT M JAMES

Large shareholder
13 382 -0.6%
1,20
16 060 USD 		13 382 -0.6% 1,20 16 060 USD
2016-07-15 2016-07-13 V Vente

New Enterprise Associates 12, Limited Partnership

Large shareholder
13 382 -0.6%
1,20
16 060 USD 		13 382 -0.6% 1,20 16 060 USD
2015-02-02 2015-01-30 A Achat

BARRETT M JAMES

Administrateur non-exécutif Large shareholder
23 457 +1.1%
11,00
258 027 USD 		23 457 +1.1% 11,00 258 027 USD
2015-02-02 2015-01-30 A Achat

New Enterprise Associates 12, Limited Partnership

Large shareholder
23 457 +1.1%
11,00
258 027 USD 		23 457 +1.1% 11,00 258 027 USD
2015-02-02 2015-01-30 A Achat

BioMed Realty Trust Inc

Large shareholder
26 543 +5.1%
11,00
291 973 USD 		26 543 +5.1% 11,00 291 973 USD